Changing the way businesses create strategic partnerships, Proventa International’s Cell & Gene Therapy Strategy Meeting is not like regular medical conference in Massachusetts. Insightful, interactive and personalized, our unique format allows each c-level executive to share their valuable experiences and best practices on cell and gene therapy. Our team pre-qualifies each delegate so you can be sure to meet primary decision makers from established and emerging biotech and biopharma companies in the world.
Another hallmark of the Cell & Gene Therapy Strategy Meeting is the executive roundtable discussions. Tailor-fit to each company’s needs, these intimate sessions give way for in-depth discussion of cell development trends like biotherapeutics, CAR-T, regenerative medicine, supply chain and more. You also get the chance to raise questions that matter to your organization and share research-based insights to the conversation, an almost impossible feat when you’re at a cell therapy conference.
The Cell & Gene Therapy Strategy Meeting also connects you with your selected industry leader/s through the pre-arranged one-to-one business meetings. With our wide network of cell and gene therapy experts in the United States and worldwide, you can count to meet someone to help you strategize for your business goals. Need solutions to standardizing global logistics? Let us know so we can schedule you with a subject matter expert!
Business leaders who will benefit from attending include Chief Executive Officer, Chief Scientific Officer, SVPs, EVPs, VPs, Executive Director, Director and Global Head responsible for:
Supply Chain and Manufacturing
The Cell & Gene Therapy Strategy Meeting is happening on June 12, 2018 at The Sheraton Boston Harbour in Massachusetts. Download full agenda here.
For interested delegates and sponsors in Europe, click here for the details of the Cell & Gene Therapy Strategy Meeting happening on September 26 in Zurich, Switzerland.
To see other strategy meetings, click here.